Fetal protection against bovine viral diarrhea virus types 1 and 2 after the use of a modified-live virus vaccine

Canadian Journal of Veterinary Research

Volumn 73, Issue 4, 2009, Pages 292-297

  Xue, Wenzhi ^a   Mattick, Debra ^a   Smith, Linda ^a   Maxwell, Jon ^a  

^a Biological Research and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; NEUTRALIZING ANTIBODY; PLACEBO; UNCLASSIFIED DRUG; VISTA 5 SQ;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE DIARRHEA VIRUS INFECTION; BOVINE DIARRHEA VIRUS TYPE 1; BOVINE DIARRHEA VIRUS TYPE 2; BREEDING; CALF (BOVINE); COLOSTRUM; CONTROLLED STUDY; FEMALE; FETUS; GESTATIONAL AGE; HEIFER; INFECTION PREVENTION; KIDNEY; LUNG; NEWBORN; NONHUMAN; PROVOCATION TEST; SPLEEN; THYMUS; TISSUE SECTION; VACCINATION; VIRUS INFECTION; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DIARRHEA VIRUS 2, BOVINE VIRAL; FEMALE; FETUS; NEUTRALIZATION TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RANDOM ALLOCATION; VACCINES, ATTENUATED; VIRAL VACCINES;

BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 71949111342     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Houe H. Economic impact of BVDV infection in dairies. Biologicals 2003;31:137-143. (Pubitemid 36593351)
2. Houe H. Epidemiological features and economical importance of bovine virus diarrhea virus (BVDV) infections. Vet Microbiol 1999;64:89-107. (Pubitemid 29073588)
3. Baker JC. The clinical manifestations of bovine viral diarrhea infection. Vet Clin North Am Food Anim Pract 1995;11:425-445.
4. Radostits OM, Littlejohns IR. New concepts in the pathogenesis, diagnosis and control of diseases caused by the bovine viral diarrhea virus. Can Vet J 1988;29:513-528.
5. Goens SD. The evolution of bovine viral diarrhea: A review. Can Vet J 2002;43:946-954. (Pubitemid 36267498)
6. Evermann JF, Ridpath JF. Clinical and epidemiologic observations of bovine viral diarrhea virus in the northwestern United States. Vet Microbiol 2002;89:129-139.
7. Brock KV, Grooms DL, Givens MD. Reproductive disease and persistent infections. In: Goyal SM, Ridpath JF, eds. Bovine Viral Diarrhea Virus: Diagnosis, Management, and Control. Ames, Iowa: Blackwell Publ, 2005:145-156.
8. Muñoz-Zanzi CA, Hietala SK, Thurmond MC, Johnson WO. Quantification, risk factors, and health impact of natural congenital infection with bovine viral diarrhea virus in diary calves [published erratum appears in Am J Vet Res 2003;64:568]. Am J Vet Res 2003;64:358-365.
9. McClurkin AW, Littledike ET, Cutlip RC, Frank GH, Coria MF, Bolin SR. Production of cattle immunotolerant to bovine viral diarrhea virus. Can J Comp Med 1984;48:156-161. (Pubitemid 14148067)
10. Houe H, Baker JC, Maes RK, et al. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody-positive cattle among herds with different infection and vaccination status. J Vet Diagn Invest 1995;7:321-326.
11. Wittum TE, Grotelueschen DM, Brock KV, et al. Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 2001;49:83-94. (Pubitemid 32247599)
12. Loneragan GH, Thomson DU, Montgomery DL, Mason GL, Larson RL. Prevalence, outcome, and health consequences associated with persistent infection with bovine viral diarrhea virus in feedlot cattle. J Am Vet Med Assoc 2005;226:595-601.
13. Swasdipan S, McGowan M, Phillips N, Bielefeld-Ohmann H. Pathogenesis of transplacental virus infection: Pestivirus replication in the placenta and fetus following respiratory infection. Microbial Pathogenesis 2002;32:49-60. (Pubitemid 34969206)
14. Fredriksen B, Press CM, Loken T, Odegaard SA. Distribution of viral antigen in uterus, placenta and foetus of cattle persistently infected with bovine virus diarrhoea virus. Vet Microbiol 1999;64:109-122. (Pubitemid 29073589)
15. Cortese VS, Grooms DL, Ellis J, Bolin SR, Ridpath JF, Brock KV. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 1998;59:1409-1413. (Pubitemid 28531222)
16. Brock KV, Cortese VS. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Therapeutics 2001;2:354-360.
17. Kovács F, Magyar T, Rinehart C, Elbers K, Schlesinger K, Ohnesorge WC. The live attenuated bovine viral diarrhea virus components of multi-valent vaccine confer protection against fetal infection. Vet Microbiol 2003;96:117-131. (Pubitemid 38352793)
18. Frey HR, Eicken K, Grummer B, Kenklies S, Oguzoglu TC, Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J Vet Med B Infect Dis Vet Public Health 2002;49:489-493. (Pubitemid 36093115)
19. Dean HJ, Hunsaker BD, Bailey OD, Wasmoen T. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 2003;64:530-537. (Pubitemid 36575718)
20. Ficken MD, Ellsworth MA, Tucker CM, Cortese VS. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation [published erratum appears in J Am Vet Med Assoc 2006;228:1904]. J Am Vet Med Assoc 2006;228:1559-1564.
21. Schnackel JA, Van Campen H, van Olphen A. Modified-live bovine viral diarrhea virus (BVDV) type la vaccine provides protection against fetal infection after challenge with either type lb or type 2 BVDV. Bovine Practitioner 2007;41(Pt1):1-9.
22. Grooms DL, Bolin SR, Coe PH, Borges RJ, Coutu CE. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle. Am J Vet Res 2007;68:1417-1422.
23. Harding MJ, Cao X, Shams H, et al. Role of bovine viral diarrhea virus biotype in the establishment of fetal infections. Am J Vet Res 2002;63:1455-1463. (Pubitemid 35153992)
24. Brownlie J, Clarke MC, Howard CJ. Experimental infection of cattle in early pregnancy with a cytopathic strain of bovine virus diarrhoea virus. Res Vet Sci 1989;46:307-311.
25. Liess B, Orban S, Frey HR, Trautwein G. Consequences of the transplacental transmission of BVD virus to cattle fetuses. Dtsch Tierarztl Wochenschr 1987;94:585-587.
26. Brock KV, Chase CCL. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines. Vet Microbiol 2000;77:209-214.
27. Duffell SJ, Sharp MW, Winkler CE, et al. Bovine virus diarrhoeamucosal disease virus-induced fetopathy in cattle: Efficacy of prophylactic maternal pre-exposure. Vet Rec 1984;114:558-561.
28. Roeder PL, Jeffrey M, Cranwell MP. Pestivirus fetopathogenicity in cattle: Changing sequelae with fetal maturation. Vet Rec 1986;118:44-48.
29. Walz PH, Bell TG, Wells JL, et al. Relationship between degree of viremia and disease manifestation in calves with experimentally induced bovine viral diarrhea virus infection. Am J Vet Res 2001;62:1095-1103.